|国家科技期刊平台
首页|期刊导航|基础医学与临床|乳腺癌类器官的培养及鉴定

乳腺癌类器官的培养及鉴定OACSTPCD

Culture and characterization of breast cancer organoids

中文摘要英文摘要

目的 建立乳腺癌类器官并长期培养,鉴定其相关分子特征及对相关药物的敏感性.方法 乳腺癌患者手术标本,胶原酶消化法,获取细胞进行类器官培养,进行形态学观察,免疫荧光检测ER、PR、HER-2、CK表达,对其中3 例类器官进行紫杉醇、多柔比星、顺铂药敏测试.结果 共培养建立了 44 例乳腺癌类器官,均呈实性类球状生长.类器官ER、PR、HER-2、CK表达情况与患者临床样品一致.乳腺癌类器官对化疗药紫杉醇、多柔比星、顺铂具有一定敏感性.结论 乳腺癌类器官作为新型体外模型,具有一定异质性,再现体内病生理功能特性.

Objective To establish breast cancer organoids for a long time and to characterize their molecular ex-pression and test their sensitivity to chemotherapy drugs.Methods Breast cancer specimens were digested with col-lagenase to release cancer cells for organoid culture.The organoids were characterized by morphology and ER,PR,HER-2,CK expression by technology of histoimmunofluorescence.Among them,three were tested for paclitaxel,doxorubicin and cisplatin sensitivity.Results A total of 44 cases of breast cancer organoids were established,all of which showed dense spherical-like growth and ER,PR,HER-2,CK,matching their clinical counterpart.Breast cancer organoids were sensitive to chemotherapy drugs paclitaxel,doxorubicin and cisplatin.Conclusions Organoid model,as a new in vitro may reproduce the pathophysiology features with heterogeneity.

夏雨佳;杨振丽;代娣;刘玉琴

中国医学科学院基础医学研究所 北京协和医学院基础学院 病理学系,北京 100005

临床医学

乳腺癌类器官药敏实验

breast cancerorganoiddrug sensitive test

《基础医学与临床》 2024 (009)

1223-1228 / 6

中国医学科学院医学与健康科技创新工程-重大协同创新项目(2021-I2M-1-053)

10.16352/j.issn.1001-6325.2024.09.1223

评论